scholarly journals Multi Drug Resistant Tuberculosis Clusters in Mpumalanga Province, South Africa, 2013‐2016: A Spatial Analysis

2021 ◽  
Author(s):  
M.A. Mashamba ◽  
F. Tanser ◽  
S. Afagbedzi ◽  
A. Beke
Keyword(s):  
South Africa ◽  
Spatial Analysis ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Mpumalanga Province ◽  
Resistant Tuberculosis ◽  
Multi Drug Resistant Tuberculosis

scholarly journals Multi-drug-resistant tuberculosis (MDR-TB): Current situation in South Africa

2017 ◽  
Vol 59 (2) ◽  
pp. 5
Author(s):  
Gboyega A Ogunbanjo
Keyword(s):  
South Africa ◽  
Soviet Union ◽  
Former Soviet Union ◽  
Drug Resistant ◽  
First Line ◽  
Drug Resistant Tuberculosis ◽  
Resistant Tuberculosis ◽  
Multi Drug Resistant Tuberculosis ◽  
Mdr Tb ◽  
Previously Treated

Multi-drug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection which is resistant to treatment with at least two of the most powerful first-line anti-TB drugs, namely isoniazid and rifampicin. Globally, MDR-TB caused an estimated 480 000 new TB cases and 250 000 deaths in 2015 and accounted for 3.3% of all new TB cases worldwide.1 MDR-TB, or rifampicin-resistant TB, causes 3.9% of new TB cases and 21% of previously treated TB cases, and most MDR-TB cases occur in South America, southern Africa, India, China, and the former Soviet Union.1

scholarly journals Malabsorption syndrome as a manifestation of systemic effects in advanced forms of pulmonary tuberculosis

2014 ◽  
Vol 18 (3 (71)) ◽  
Author(s):  
L. D. Todoriko ◽  
I. V. Yeremenchuk ◽  
V. P. Shapovalov ◽  
T. I. Ilchyshyn
Keyword(s):  
South Africa ◽  
Epidemiological Surveillance ◽  
Systemic Effects ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Resistant Tuberculosis ◽  
Extensively Drug Resistant ◽  
Multi Drug Resistant Tuberculosis ◽  
The World ◽  
Mdr Tb

As of October 2012 84 countries had reported at least 1 case of extensively drug resistant tuberculosis (EDR TB). In November 2012, the WHO epidemiological surveillance stated: all new TB cases in the world are 3,7 % of multi-drug resistant tuberculosis (MDR TB); 60,0 % of MDR TB among the new cases of TB are documented in Brazil, China, India, and South Africa.

scholarly journals Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa

2012 ◽  
Vol 18 (1) ◽  
pp. 109-116 ◽  
Author(s):  
Kathryn Schnippel ◽  
Sydney Rosen ◽  
Kate Shearer ◽  
Neil Martinson ◽  
Lawrence Long ◽  
...  
Keyword(s):  
South Africa ◽  
Inpatient Treatment ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Resistant Tuberculosis ◽  
Multi Drug Resistant Tuberculosis
Sign in / Sign up

Export Citation Format

Share Document